{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:12:22Z","timestamp":1791609142408,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Robert Koch-Institut"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Beim ersten Auftreten des Erregers SARS-CoV\u20112 im Dezember 2019 standen weder spezifische therapeutische M\u00f6glichkeiten noch ein Impfstoff zur Verf\u00fcgung. Auch in Deutschland r\u00fcckten deshalb nichtpharmakologische Ma\u00dfnahmen zur Kontrolle der COVID-19-Pandemie in den Vordergrund. Am Robert Koch-Institut wurde eine Multikomponentenstrategie aus bev\u00f6lkerungsbasierten und individuellen infektionshygienischen Ma\u00dfnahmen entwickelt, die auf bestehenden Influenzapandemiepl\u00e4nen und generischen Planungen aufbaute. Der Beitrag erl\u00e4utert die empfohlenen nichtpharmakologischen Ma\u00dfnahmen und stellt die parallel entwickelten pharmakologischen Ans\u00e4tze dar.<\/jats:p><jats:p>Zu den bev\u00f6lkerungsbasierten Ma\u00dfnahmen geh\u00f6ren u.\u202fa. allgemeine Kontaktbeschr\u00e4nkungen, die Versorgung mit Materialien f\u00fcr den Infektionsschutz, Veranstaltungsverbote, die Schlie\u00dfung von Bildungseinrichtungen und die Beschr\u00e4nkung des Reiseverkehrs. Zus\u00e4tzlich sind individuelle infektionshygienische Ma\u00dfnahmen notwendig: z.\u202fB. Einhaltung eines Mindestabstands, Reduktion von Kontakten, Tragen einer Mund-Nasen-Bedeckung sowie Einhaltung von Quarant\u00e4ne und Isolierung. Die Ma\u00dfnahmen im Gesundheitswesen bauen auf Empfehlungen der Kommission f\u00fcr Krankenhaushygiene und Infektionspr\u00e4vention (KRINKO) auf und werden von den Fachgesellschaften spezifiziert und implementiert. Als pharmakologische Ma\u00dfnahmen stehen mit Stand November 2020 eine antivirale Therapie mit Remdesivir und die Behandlung mit dem Glucocorticoid Dexamethason zur Verf\u00fcgung. Monoklonale Antik\u00f6rper sind zu diesem Zeitpunkt noch nicht zugelassen. Die therapeutische Antikoagulation wird empfohlen.<\/jats:p><jats:p>Die Empfehlungen werden kontinuierlich an die wachsende Kenntnis der Eigenschaften und \u00dcbertragungswege des Erregers angepasst. Eine gro\u00dfe Herausforderung besteht darin, das Vertrauen der Bev\u00f6lkerung in die empfohlenen Ma\u00dfnahmen zu st\u00e4rken. Viele Ma\u00dfnahmen m\u00fcssen individuell angewandt werden, um gemeinsam zu wirken.<\/jats:p>","DOI":"10.1007\/s00103-021-03306-z","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T12:02:46Z","timestamp":1617192166000},"page":"435-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ma\u00dfnahmen zur Bew\u00e4ltigung der COVID-19-Pandemie in Deutschland: nichtpharmakologische und pharmakologische Ans\u00e4tze","Measures to cope with the COVID-19 pandemic in Germany: nonpharmaceutical and pharmaceutical interventions"],"prefix":"10.1007","volume":"64","author":[{"given":"Ulrike","family":"Grote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardjan","family":"Arvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Brinkwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Brunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Eckmanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"von Kleist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Niebank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Ruehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stoliaroff-P\u00e9pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Thanheiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Schaade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunja","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"3306_CR1","first-page":"61","volume":"2004","author":"Robert Koch-Institut","year":"2004","unstructured":"Robert Koch-Institut (2004) SARS-Epidemie im Jahr 2003: Ein R\u00fcckblick auf die Aktivit\u00e4ten des RKI (Teil 1). Epidemiol Bull 2004:61\u201364 (https:\/\/www.rki.de\/DE\/Content\/Infekt\/Krankenhaushygiene\/Erreger_ausgewaehlt\/SARS\/SARS_pdf_02.pdf?__blob=publicationFile Zugriffen: 17.02.2021)","journal-title":"Epidemiol Bull"},{"key":"3306_CR2","unstructured":"World Health Organization (2020) MERS situation update, January 2020. https:\/\/applications.emro.who.int\/docs\/EMCSR254E.pdf?ua=1ua=1. Zugegriffen: 27. Nov. 2020"},{"key":"3306_CR3","first-page":"23","volume-title":"Gesundheitsministerkonferenz der L\u00e4nder","author":"Unter-Arbeitsgruppe \u201ePandemieplanung\u201c der AG Infektionsschutz","year":"2017","unstructured":"Unter-Arbeitsgruppe \u201ePandemieplanung\u201c der AG Infektionsschutz (2017) Infektionshygienische Ma\u00dfnahmen. In: Nationaler Pandemieplan Teil Strukturen Ma\u00dfnahmen (Hrsg) Gesundheitsministerkonferenz der L\u00e4nder. Gesundheitsministerkonferenz der L\u00e4nder, Rober Koch-Institut, S 23\u201332"},{"key":"3306_CR4","volume-title":"Nationaler Pandemieplan Teil II \u2013 Wissenschaftliche Grundlagen","author":"A Reuss","year":"2016","unstructured":"Reuss\u00a0A, Gastmeier\u00a0P, Bornhofen\u00a0B, Yvonne\u00a0B, Haas\u00a0W, Buchholz\u00a0U (2016) Nicht-pharmakologische Ma\u00dfnahmen. In: Robert Koch Institut, Expertenbeirat Influenza (Hrsg) Nationaler Pandemieplan Teil II \u2013 Wissenschaftliche Grundlagen"},{"key":"3306_CR5","unstructured":"Robert Koch-Institut (2019) Epidemisch bedeutsame Lagen erkennen, bewerten und gemeinsam erfolgreich bew\u00e4ltigen. https:\/\/www.rki.de\/DE\/Content\/Infekt\/Preparedness_Response\/Rahmenkonzept_Epidemische_bedeutsame_Lagen.pdf;jsessionid=9EE76093AFD52831804A4522363352CF.internet052?__blob=publicationFile. Zugegriffen: 27. Nov. 2020"},{"key":"3306_CR6","unstructured":"Bundesregierung (2020) Besprechung der Bundeskanzlerin mit den Regierungschefinnen und Regierungschefs der L\u00e4nder am 12. M\u00e4rz 2020. https:\/\/www.bundesregierung.de\/breg-de\/themen\/coronavirus\/beschluss-zu-corona-1730292. Zugegriffen: 15.\u00a0Okt.\u00a02020"},{"key":"3306_CR7","unstructured":"Bundesregierung (2020) Vereinbarung zwischen der Bundesregierung und den Regierungschefinnen und Regierungschefs der Bundesl\u00e4nder angesichts der Corona-Epidemie in Deutschland. https:\/\/www.bundesregierung.de\/breg-de\/aktuelles\/vereinbarung-zwischen-der-bundesregierung-und-den-regierungschefinnen-und-regierungsschef-der-bundeslaender-angesichts-der-corona-epidemie-in-deutschland-1730934. Zugegriffen: 15. Okt. 2020"},{"key":"3306_CR8","unstructured":"Bundesregierung (2020) Besprechung der Bundeskanzlerinmit den Regierungschefinnen undRegierungschefs der L\u00e4nderam 22. M\u00e4rz 2020. https:\/\/www.bundesregierung.de\/breg-de\/themen\/coronavirus\/besprechung-der-bundeskanzlerin-mit-den-regierungschefinnen-und-regierungschefs-der-laender-1733248. Zugegriffen: 14. Okt. 2020"},{"key":"3306_CR9","unstructured":"Bundesministerium f\u00fcr Gesundheit (2020) Coronavirus SARS-CoV-2: Chronik der bisherigen Ma\u00dfnahmen. https:\/\/www.bundesgesundheitsministerium.de\/coronavirus\/chronik-coronavirus.html. Zugegriffen: 13. Okt. 2020"},{"key":"3306_CR10","unstructured":"\u00c4rzteZeitung (2020) Corona-Gipfel: Jetzt doch fast bundesweit Schulschlie\u00dfungen. https:\/\/www.aerztezeitung.de\/Politik\/Keine-bundesweiten-Schulschliessungen-aber-Verschiebung-von-Op-407609.html. Zugegriffen: 14. Okt. 2020"},{"key":"3306_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/6731","volume":"19","author":"Robert Koch-Institut","year":"2020","unstructured":"Robert Koch-Institut (2020) Mund-Nasen-Bedeckung im \u00f6ffentlichen Raum als weitere Komponente zur Reduktion der \u00dcbertragung von COVID-19. Strategie-Erg\u00e4nzung zu empfohlenen Infektionsschutzma\u00dfnahmen und Zielen (3. Update). Epidemiol Bull 19:3\u20135. https:\/\/doi.org\/10.25646\/6731","journal-title":"Epidemiol. Bull."},{"key":"3306_CR12","unstructured":"Bundesregierung (2020) Beschluss zur Telefonschaltkonferenz der Bundeskanzlerin mit den Regierungschefinnen und Regierungschefs der L\u00e4nder am 6. Mai 2020. https:\/\/www.bundesregierung.de\/resource\/blob\/975226\/1750986\/fc61b6eb1fc1d398d66cfea79b565129\/2020-05-06-mpk-beschluss-data.pdf?download=1. Zugegriffen: 14. Okt. 2020"},{"key":"3306_CR13","series-title":"medRxiv","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.20.20134387:2020.2006.2020.20134387","volume-title":"A systematic review and meta-analysis reveals long and dispersive incubation period of COVID-19","author":"Y Wei","year":"2020","unstructured":"Wei\u00a0Y, Wei\u00a0L, Liu\u00a0Y et al (2020) A systematic review and meta-analysis reveals long and dispersive incubation period of COVID-19. medRxiv. https:\/\/doi.org\/10.1101\/2020.06.20.20134387:2020.2006.2020.20134387"},{"key":"3306_CR14","series-title":"medRxiv.","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.24.20073957","volume-title":"The incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research","author":"CG McAloon","year":"2020","unstructured":"McAloon\u00a0CG, Collins\u00a0A, Hunt\u00a0K et al (2020) The incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research. medRxiv.. https:\/\/doi.org\/10.1101\/2020.04.24.20073957"},{"key":"3306_CR15","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li\u00a0Q, Guan\u00a0X, Wu\u00a0P et al (2020) Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. N\u00a0Engl J Med 382:1199\u20131207. https:\/\/doi.org\/10.1056\/NEJMoa2001316","journal-title":"N Engl J Med"},{"key":"3306_CR16","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1017\/s0950268820001338","volume":"148","author":"L Yang","year":"2020","unstructured":"Yang\u00a0L, Dai\u00a0J, Zhao\u00a0J, Wang\u00a0Y, Deng\u00a0P, Wang\u00a0J (2020) Estimation of incubation period and serial interval of COVID-19: analysis of 178\u00a0cases and 131 transmission chains in Hubei province, China. Epidemiol Infect 148:e117. https:\/\/doi.org\/10.1017\/s0950268820001338","journal-title":"Epidemiol Infect"},{"key":"3306_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020538","author":"NM Linton","year":"2020","unstructured":"Linton\u00a0NM, Kobayashi\u00a0T, Yang\u00a0Y et\u00a0al (2020) Incubation period and other epidemiological characteristics of 2019 novel Coronavirus infections with right truncation: a statistical analysis of publicly available case data. JCM. https:\/\/doi.org\/10.3390\/jcm9020538","journal-title":"JCM"},{"key":"3306_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/m20-0504","volume":"172","author":"SA Lauer","year":"2020","unstructured":"Lauer\u00a0SA, Grantz\u00a0KH, Bi\u00a0Q et al (2020) The incubation period of Coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 172:577\u2013582. https:\/\/doi.org\/10.7326\/m20-0504","journal-title":"Ann Intern Med"},{"key":"3306_CR19","volume-title":"Epidemiologischer Steckbrief zu SARS-CoV-2 und COVID-19","author":"Robert Koch-Institut","year":"2020","unstructured":"Robert Koch-Institut (2020) Epidemiologischer Steckbrief zu SARS-CoV\u20112 und COVID-19"},{"key":"3306_CR20","series-title":"medRxiv","doi-asserted-by":"publisher","DOI":"10.1101\/2020.11.18.20233825","volume-title":"COVIDStrategyCalculator: A standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation","author":"W van der Toorn","year":"2020","unstructured":"van der Toorn\u00a0W, Oh\u00a0D\u2011Y, Bourquain\u00a0D et al (2020) COVIDStrategyCalculator: A standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation. medRxiv. https:\/\/doi.org\/10.1101\/2020.11.18.20233825"},{"key":"3306_CR21","series-title":"medRxiv : the preprint server for health sciences","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.29.20164590","volume-title":"Household transmission of SARS-CoV-2: a\u00a0systematic review and meta-analysis of secondary attack rate","author":"ZJ Madewell","year":"2020","unstructured":"Madewell\u00a0ZJ, Yang\u00a0Y, Longini\u00a0IM, Halloran\u00a0ME, Dean\u00a0NE (2020) Household transmission of SARS-CoV-2: a\u00a0systematic review and meta-analysis of secondary attack rate. medRxiv : the preprint server for health sciences. https:\/\/doi.org\/10.1101\/2020.07.29.20164590"},{"key":"3306_CR22","doi-asserted-by":"publisher","first-page":"e0240205","DOI":"10.1371\/journal.pone.0240205","volume":"15","author":"WC Koh","year":"2020","unstructured":"Koh\u00a0WC, Naing\u00a0L, Chaw\u00a0L et al (2020) What do we know about SARS-CoV\u20112 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PLoS ONE 15:e240205. https:\/\/doi.org\/10.1371\/journal.pone.0240205","journal-title":"PLoS ONE"},{"key":"3306_CR23","unstructured":"Robert Koch-Institut (2020) Kontaktpersonen-Nachverfolgung bei SARS-CoV-2-Infektionen. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Kontaktperson\/Management.html. Zugegriffen: 17. Febr. 2021"},{"key":"3306_CR24","doi-asserted-by":"publisher","first-page":"091701","DOI":"10.1063\/5.0022968","volume":"32","author":"S Verma","year":"2020","unstructured":"Verma\u00a0S, Dhanak\u00a0M, Frankenfield\u00a0J (2020) Visualizing droplet dispersal for face shields and masks with exhalation valves. Phys Fluids 32:91701. https:\/\/doi.org\/10.1063\/5.0022968","journal-title":"Phys Fluids"},{"key":"3306_CR25","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2020.244","author":"M Ippolito","year":"2020","unstructured":"Ippolito\u00a0M, Iozzo\u00a0P, Gregoretti\u00a0C, Grasselli\u00a0G, Cortegiani\u00a0A (2020) Facepiece filtering respirators with exhalation valve should not be used in the community to limit SARS-CoV\u20112 diffusion. Infect Control Hosp Epidemiol. https:\/\/doi.org\/10.1017\/ice.2020.244","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3306_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/dmp.2013.43","volume":"7","author":"A Davies","year":"2013","unstructured":"Davies\u00a0A, Thompson\u00a0KA, Giri\u00a0K, Kafatos\u00a0G, Walker\u00a0J, Bennett\u00a0A (2013) Testing the efficacy of homemade masks: would they protect in an influenza pandemic? Disaster med public health prep 7:413\u2013418. https:\/\/doi.org\/10.1017\/dmp.2013.43","journal-title":"Disaster med public health prep"},{"key":"3306_CR27","doi-asserted-by":"publisher","first-page":"105617","DOI":"10.1016\/j.jaerosci.2020.105617","volume":"148","author":"CJ K\u00e4hler","year":"2020","unstructured":"K\u00e4hler\u00a0CJ, Hain\u00a0R (2020) Fundamental protective mechanisms of face masks against droplet infections. J\u00a0Aerosol Sci 148:105617. https:\/\/doi.org\/10.1016\/j.jaerosci.2020.105617","journal-title":"J Aerosol Sci"},{"key":"3306_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd3083","author":"EP Fischer","year":"2020","unstructured":"Fischer\u00a0EP, Fischer\u00a0MC, Grass\u00a0D, Henrion\u00a0I, Warren\u00a0WS, Westman\u00a0E (2020) Low-cost measurement of face mask efficacy for filtering expelled droplets during speech. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abd3083","journal-title":"Sci Adv"},{"key":"3306_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/a-1175-8578","volume":"74","author":"D Dellweg","year":"2020","unstructured":"Dellweg\u00a0D, Lepper\u00a0PM, Nowak\u00a0D, K\u00f6hnlein\u00a0T, Olgem\u00f6ller\u00a0U, Pfeifer\u00a0M (2020) Position paper of the German Respiratory Society (DGP) on the impact of community masks on self-protection and protection of others in regard to Aerogen transmitted diseases. Pneumologie 74:331\u2013336. https:\/\/doi.org\/10.1055\/a-1175-8578","journal-title":"Pneumologie"},{"key":"3306_CR30","unstructured":"Robert Koch-Institut (2021) Antworten auf h\u00e4ufig gestellte Fragen zum Coronavirus SARS-CoV\u20112 \/ Krankheit COVID-19. https:\/\/www.rki.de\/SharedDocs\/FAQ\/NCOV2019\/gesamt.html. Zugegriffen: 17. Febr. 2021"},{"key":"3306_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.idm.2020.04.001","volume":"5","author":"SE Eikenberry","year":"2020","unstructured":"Eikenberry\u00a0SE, Mancuso\u00a0M, Iboi\u00a0E et al (2020) To mask or not to mask: modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infect Dis Model 5:293\u2013308. https:\/\/doi.org\/10.1016\/j.idm.2020.04.001","journal-title":"Infect Dis Model"},{"key":"3306_CR32","doi-asserted-by":"publisher","first-page":"104924","DOI":"10.1016\/j.ssci.2020.104924","volume":"131","author":"T Wieland","year":"2020","unstructured":"Wieland\u00a0T (2020) A phenomenological approach to assessing the effectiveness of COVID-19 related nonpharmaceutical interventions in Germany. Saf Sci 131:104924. https:\/\/doi.org\/10.1016\/j.ssci.2020.104924","journal-title":"Saf Sci"},{"key":"3306_CR33","doi-asserted-by":"publisher","unstructured":"Anonymous (2016) [Not Available]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 59:1189\u20131220. https:\/\/doi.org\/10.1007\/s00103-016-2416-6","DOI":"10.1007\/s00103-016-2416-6"},{"key":"3306_CR34","doi-asserted-by":"publisher","unstructured":"Anonymous (2004) [Responsibilities of public health in cleaning and disinfection of surfaces. Recommendation by the Commitee of Hospital Hygiene and Infection Control by the Robert Koch Institute]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 47:51\u201361. https:\/\/doi.org\/10.1007\/s00103-003-0752-9","DOI":"10.1007\/s00103-003-0752-9"},{"key":"3306_CR35","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00103-015-2234-2","volume":"58","author":"C Ruscher","year":"2015","unstructured":"Ruscher\u00a0C (2015) Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 58:1151\u20131170. https:\/\/doi.org\/10.1007\/s00103-015-2234-2","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3306_CR36","unstructured":"Bundesanstalt f\u00fcr Arbeitsschutz und Arbeitsmedizin (2021) Empfehlungen der BAuA zum Einsatz von Schutzmasken in der Arbeitswelt im Zusammenhang mit SARS-CoV\u20112. https:\/\/www.baua.de\/DE\/Themen\/Arbeitsgestaltung-im-Betrieb\/Coronavirus\/pdf\/Schutzmasken.pdf?__blob=publicationFilev=16. Zugegriffen: 17. Febr. 2021"},{"key":"3306_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13756-020-00810-w","volume":"9","author":"J Conly","year":"2020","unstructured":"Conly\u00a0J, Seto\u00a0WH, Pittet\u00a0D, Holmes\u00a0A, Chu\u00a0M, Hunter\u00a0PR (2020) Correction to: Use of medical face masks versus particulate respirators as a\u00a0component of personal protective equipment for health care workers in the context of the COVID-19 pandemic. Antimicrob Resist Infect Control 9:151. https:\/\/doi.org\/10.1186\/s13756-020-00810-w","journal-title":"Antimicrob Resist Infect Control"},{"key":"3306_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13756-020-00779-6","volume":"9","author":"J Conly","year":"2020","unstructured":"Conly\u00a0J, Seto\u00a0WH, Pittet\u00a0D, Holmes\u00a0A, Chu\u00a0M, Hunter\u00a0PR (2020) Use of medical face masks versus particulate respirators as a\u00a0component of personal protective equipment for health care workers in the context of the COVID-19 pandemic. Antimicrob Resist Infect Control 9:126. https:\/\/doi.org\/10.1186\/s13756-020-00779-6","journal-title":"Antimicrob Resist Infect Control"},{"key":"3306_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00103-003-0752-9","volume":"47","author":"Kommission f\u00fcr Krankenhaushygieneund Infektionspr\u00e4vention beim Robert Koch-Institut (RKI)","year":"2004","unstructured":"Kommission f\u00fcr Krankenhaushygieneund Infektionspr\u00e4vention beim Robert Koch-Institut (RKI) (2004) Anforderungen an die Hygiene bei der Reinigungund Desinfektion von Fl\u00e4chen \u2013 Empfehlung der Kommission f\u00fcr Krankenhaushygieneund Infektionspr\u00e4vention beim Robert Koch-Institut (RKI). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:51\u201361. https:\/\/doi.org\/10.1007\/s00103-003-0752-9","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3306_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00103-016-2509-2","volume":"60","author":"I Schwebke","year":"2017","unstructured":"Schwebke\u00a0I, Eggers\u00a0M, Gebel\u00a0J et\u00a0al (2017) Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 60:353\u2013363. https:\/\/doi.org\/10.1007\/s00103-016-2509-2","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3306_CR41","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1056\/NEJMp2006372","volume":"382","author":"M Klompas","year":"2020","unstructured":"Klompas\u00a0M, Morris\u00a0CA, Sinclair\u00a0J, Pearson\u00a0M, Shenoy\u00a0ES (2020) Universal Masking in Hospitals in the Covid-19 Era. N\u00a0Engl J Med 382:e63. https:\/\/doi.org\/10.1056\/NEJMp2006372","journal-title":"N Engl J Med"},{"key":"3306_CR42","unstructured":"Robert Koch-Institut (2021) Erweiterte Hygienema\u00dfnahmen im Gesundheitswesen im Rahmen der COVID-19 Pandemie. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/erweiterte_Hygiene.html. Zugegriffen: 17. Febr. 2021"},{"key":"3306_CR43","doi-asserted-by":"publisher","unstructured":"Fachgruppe COVRIIN am Robert Koch-Institut Welche Rolle spielt ein m\u00f6gliches Hyperinflammationssyndrom bei einer schweren COVID-19-Infektion und k\u00f6nnen hieraus Konsequenzen f\u00fcr die Therapie gezogen werden? https:\/\/doi.org\/10.25646\/703710.25646\/7037. Zugegriffen: 17.02.2021","DOI":"10.25646\/703710.25646\/7037"},{"key":"3306_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","volume":"39","author":"HK Siddiqi","year":"2020","unstructured":"Siddiqi\u00a0HK, Mehra\u00a0MR (2020) COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J\u00a0Heart Lung Transplant 39:405\u2013407. https:\/\/doi.org\/10.1016\/j.healun.2020.03.012","journal-title":"J Heart Lung Transplant"},{"key":"3306_CR45","unstructured":"European Medicines Agency (2020) Human medicines European public assessment report (EPAR): Veklury, remdesivir, Coronavirus Infections. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/veklury#authorisation-details-section. Zugegriffen: 9. Dez. 2020"},{"key":"3306_CR46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","author":"WS Lim","year":"2020","unstructured":"RECOVERY Collaborative Group HP, Lim\u00a0WS, Emberson\u00a0JR, Mafham\u00a0M, Bell\u00a0JL, Linsell\u00a0L, Staplin\u00a0N, Brightling\u00a0C, Ustianowski\u00a0A, Elmahi\u00a0E, Prudon\u00a0B, Green\u00a0C, Felton\u00a0T, Chadwick\u00a0D, Rege\u00a0K, Fegan\u00a0C, Chappell\u00a0LC, Faust\u00a0SN, Jaki\u00a0T, Jeffery\u00a0K, Montgomery\u00a0A, Rowan\u00a0K, Juszczak\u00a0E, Baillie\u00a0JK, Haynes\u00a0R, Landray\u00a0MJ (2020) Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"3306_CR47","doi-asserted-by":"publisher","unstructured":"St\u00e4ndiger Arbeitskreis der Kompetenz- und Behandlungszentren f\u00fcr Krankheiten durch hochpathogene Erreger am Robert Koch-Institut Hinweise zu Erkennung, Diagnostik und Therapie von Patienten mit COVID-19 https:\/\/doi.org\/10.25646\/6539.17","DOI":"10.25646\/6539.17"},{"key":"3306_CR48","unstructured":"European Medicines Agency (2020) EMA endorses use of dexamethasone in COVID-19\u00a0patients on oxygen or mechanical ventilation. https:\/\/www.ema.europa.eu\/en\/news\/ema-endorses-use-dexamethasone-covid-19-patients-oxygen-mechanical-ventilation. Zugegriffen: 9. Dez. 2020"},{"key":"3306_CR49","unstructured":"Food and Drug Administration (FDA) (2020) Letter of authorization: Bamlanivimab. https:\/\/www.fda.gov\/media\/143602\/download. Zugegriffen: 10. Nov. 2020"},{"key":"3306_CR50","unstructured":"Food and Drug Administration (FDA) (2020) Letter of Authorization: Casirivimab and Imdevimab. https:\/\/www.fda.gov\/media\/143891\/download. Zugegriffen: 21. Nov. 2020"},{"key":"3306_CR51","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","volume":"76","author":"GN Nadkarni","year":"2020","unstructured":"Nadkarni\u00a0GN, Lala\u00a0A, Bagiella\u00a0E et al (2020) Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J\u00a0Am Coll Cardiol 76:1815\u20131826 (http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735109720364081 Zugegriffen: 15.10.2020)","journal-title":"J Am Coll Cardiol"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-021-03306-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-021-03306-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-021-03306-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T11:24:01Z","timestamp":1619004241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-021-03306-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3306"],"URL":"https:\/\/doi.org\/10.1007\/s00103-021-03306-z","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"5 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Grote, M.\u00a0Arvand, S.\u00a0Brinkwirth, M.\u00a0Brunke, U.\u00a0Buchholz, T.\u00a0Eckmanns, M.\u00a0von Kleist, M.\u00a0Niebank, B.\u00a0Ruehe, K.\u00a0Schulze, A.\u00a0Stoliaroff-P\u00e9pin, M.\u00a0Thanheiser, L.\u00a0Schaade, D.\u00a0Said und W.\u00a0Haas geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}